Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39f5f8c5e3447cec21cf9537be5de490 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
filingDate |
2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff49bded531e4570375a6283437afa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d29445109346181e5160f8e79d2fd684 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32fa295cc8755abd20540f92565bb762 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_339aee1735af5eb3830b7e4a0a654c42 |
publicationDate |
2012-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2453017-A9 |
titleOfInvention |
Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases |
abstract |
The present invention refers to an oligonucleotide for use in prophylaxis and/or treatment of a TGF-beta1 and TGF-beta 2 mRNA overexpressing tumor, a TGF-beta2 and TGF-beta3 mRNA overexpressing tumor, a TGF-beta1 and TGF-beta3 mRNA overexpressing tumor, or a TGF-beta1, TGF-beta 2, and TGF-beta3 mRNA overexpressing tumor. |
priorityDate |
2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |